Coagulation Factor Xa Has No Effects on the Expression of PAR1, PAR2, and PAR4 and No Proinflammatory Effects on HL-1 Cells.

Ruf L, Bukowska A, Gardemann A, Goette A.Cells. 2023 Dec 15;12(24):2849. doi: 10.3390/cells12242849.PMID: 38132169 Free PMC article.

 

Heart Failure, Female Sex, and Atrial Fibrillation Are the Main Drivers of Human Atrial Cardiomyopathy: Results From the CATCH ME Consortium.

Winters J, Isaacs A, Zeemering S, Kawczynski M, Maesen B, Maessen J, Bidar E, Boukens B, Hermans B, van Hunnik A, Casadei B, Fabritz L, Chua W, Sommerfeld L, Guasch E, Mont L, Batlle M, Hatem S, Kirchhof P, Wakili R, Sinner M, Stoll M, Goette A, Verheule S, Schotten U.J Am Heart Assoc. 2023 Nov 20;12(22):e031220. doi: 10.1161/JAHA.123.031220. Online ahead of print.PMID: 37982389 Free PMC article.

 

Anticoagulation with edoxaban in patients with long Atrial High-Rate Episodes ≥24 hours.

Becher N, Toennis T, Bertaglia E, Blomström-Lundqvist C, Brandes A, Cabanelas N, Calvert M, Camm AJ, Chlouverakis G, Dan GA, Dichtl W, Diener HC, Fierenz A, Goette A, de Groot JR, Hermans ANL, Lip GYH, Lubinski A, Marijon E, Merkely B, Mont L, Ozga AK, Rajappan K, Sarkozy A, Scherr D, Schnabel RB, Schotten U, Sehner S, Simantirakis E, Vardas P, Velchev V, Wichterle D, Zapf A, Kirchhof P.Eur Heart J. 2023 Nov 12:ehad771. doi: 10.1093/eurheartj/ehad771. Online ahead of print.PMID: 37956458

 

Direct Oral Anticoagulants for Stroke Prevention in Patients with Device-Detected Atrial Fibrillation: A Study-Level Meta-Analysis of the NOAH-AFNET 6 and ARTESiA Trials.

McIntyre WF, Benz AP, Becher N, Healey JS, Granger CB, Rivard L, Camm AJ, Goette A, Zapf A, Alings M, Connolly SJ, Kirchhof P, Lopes RD.Circulation. 2023 Nov 12. doi: 10.1161/CIRCULATIONAHA.123.067512. Online ahead of print.PMID: 37952187

 

Edoxaban in patients with non-valvular atrial fibrillation after percutaneous coronary intervention: ENCOURAGE-AF design.

Baldus S, Beyer-Westendorf J, Möllmann H, Rottbauer W, Beyerlein E, Goette A.Sci Rep. 2023 Oct 25;13(1):18215. doi: 10.1038/s41598-023-44345-7.PMID: 37880316 Free PMC article.

 

Anticoagulation with Edoxaban in Patients with Atrial High-Rate Episodes.

Kirchhof P, Toennis T, Goette A, Camm AJ, Diener HC, Becher N, Bertaglia E, Blomstrom Lundqvist C, Borlich M, Brandes A, Cabanelas N, Calvert M, Chlouverakis G, Dan GA, de Groot JR, Dichtl W, Kravchuk B, Lubiński A, Marijon E, Merkely B, Mont L, Ozga AK, Rajappan K, Sarkozy A, Scherr D, Sznajder R, Velchev V, Wichterle D, Sehner S, Simantirakis E, Lip GYH, Vardas P, Schotten U, Zapf A; NOAH-AFNET 6 Investigators.N Engl J Med. 2023 Sep 28;389(13):1167-1179. doi: 10.1056/NEJMoa2303062. Epub 2023 Aug 25.PMID: 37622677 Clinical Trial.

 

Atrial fibrillation and stroke prevention: 25 years of research at EP Europace journal.

Lip GYH, Proietti M, Potpara T, Mansour M, Savelieva I, Tse HF, Goette A, Camm AJ, Blomstrom-Lundqvist C, Gupta D, Boriani G.Europace. 2023 Aug 2;25(9):euad226. doi: 10.1093/europace/euad226.PMID: 37622590 Free PMC article. Review.

 

Early Rhythm Control Is Therapy of Choice to Treat Atrial Fibrillation After Cerebral Stroke.

Goette A.JACC Clin Electrophysiol. 2023 Jul;9(7 Pt 2):1134-1136. doi: 10.1016/j.jacep.2023.01.016. Epub 2023 Mar 22.PMID: 37495322 No abstract available.

 

Heart transplantation for refractory ventricular tachyarrhythmia: a too stormy approach?

Goette A.Eur Heart J Acute Cardiovasc Care. 2023 Sep 25;12(9):582-583. doi: 10.1093/ehjacc/zuad085.PMID: 37479493 No abstract available.

 

Real-world utilization of the pill-in-the-pocket method for terminating episodes of atrial fibrillation: data from the multinational Antiarrhythmic Interventions for Managing Atrial Fibrillation (AIM-AF) survey.

Reiffel JA, Blomström-Lundqvist C, Boriani G, Goette A, Kowey PR, Merino JL, Piccini JP, Saksena S, Camm AJ.Europace. 2023 Jun 2;25(6):euad162. doi: 10.1093/europace/euad162.PMID: 37354453 Free PMC article.

 

Pleiotropic effects of NOACs with focus on edoxaban: scientific findings and potential clinical implications.

Goette A, Mollenhauer M, Rudolph V, Lamparter M, Meier M, Böhm M.Herzschrittmacherther Elektrophysiol. 2023 Jun;34(2):142-152. doi: 10.1007/s00399-023-00944-5. Epub 2023 May 4.PMID: 37140824 Free PMC article. Review.

 

Does epicardial fat modify the effect of catheter ablation in patients with atrial fibrillation?

Goette A.Int J Cardiol. 2023 Jul 15;383:40-41. doi: 10.1016/j.ijcard.2023.03.064. Epub 2023 Apr 6.PMID: 37028713 No abstract available.

 

Covid-19 pandemic induced traumatizing medical job contents and mental health distortions of physicians working in private practices and in hospitals.

Ladwig KH, Johar H, Miller I, Atasoy S, Goette A.Sci Rep. 2023 Mar 31;13(1):5284. doi: 10.1038/s41598-023-32412-y.PMID: 37002346 Free PMC article.

 

Is Periodontitis a Modifiable Risk Factor for Atrial Fibrillation Substrate?

Goette A.JACC Clin Electrophysiol. 2023 Jan;9(1):54-56. doi: 10.1016/j.jacep.2022.09.013. Epub 2022 Oct 31.PMID: 36697201 Free article. No abstract available.

 

[Thrombotic thrombocytopenic purpura-a differential diagnostic challenge in an emergency].

Özcan F, Köhrmann M, Petros S, Goette A, Bramlage P, Bommer M, Brokmann JC.Med Klin Intensivmed Notfmed. 2023 May;118(4):301-308. doi: 10.1007/s00063-022-00982-w. Epub 2023 Jan 4.PMID: 36598518 Free PMC article. Review. German.

 

Early rhythm-control therapy for atrial fibrillation in patients with a history of stroke: a subgroup analysis of the EAST-AFNET 4 trial.

Jensen M, Suling A, Metzner A, Schnabel RB, Borof K, Goette A, Haeusler KG, Zapf A, Wegscheider K, Fabritz L, Diener HC, Thomalla G, Kirchhof P.Lancet Neurol. 2023 Jan;22(1):45-54. doi: 10.1016/S1474-4422(22)00436-7.PMID: 36517170 Clinical Trial.

 

What acute cardiac care physicians need to know from the latest 2022 ESC Guidelines for ventricular tachycardia and sudden cardiac death.

Goette A, Lip GYH, Gorenek B.Eur Heart J Acute Cardiovasc Care. 2023 Jan 27;12(1):62-68. doi: 10.1093/ehjacc/zuac149.PMID: 36449983

 

Atrial fibrillation detection with long-term continuous Holter ECG recording in patients with high cardiovascular risk and clinical palpitations: the prospective after study.

Halimi F, Sabouret P, Huberman JP, Ouazana L, Guedj D, Djouadi K, Dhanjal TS, Goette A, Lafont C, Lellouche N.Clin Res Cardiol. 2023 Jun;112(6):807-814. doi: 10.1007/s00392-022-02109-9. Epub 2022 Sep 28.PMID: 36169720

Early rhythm-control therapy for atrial fibrillation in patients with a history of stroke: a subgroup analysis of the EAST-AFNET 4 trial. Jensen M, Suling A, Metzner A, Schnabel RB, Borof K, Goette A, Haeusler KG, Zapf A, Wegscheider K, Fabritz L, Diener HC, Thomalla G, Kirchhof P.Lancet Neurol. 2023 Jan;22(1):45-54. doi: 10.1016/S1474-4422(22)00436-7.PMID: 36517170 Clinical Trial.

What acute cardiac care physicians need to know from the latest 2022 ESC Guidelines for Ventricular Tachycardia and Sudden Cardiac Death. Goette A, Lip GYH, Gorenek B.Eur Heart J Acute Cardiovasc Care. 2022 Dec 1:zuac149. doi: 10.1093/ehjacc/zuac149. Online ahead of print.PMID: 36449983

Atrial fibrillation detection with long-term continuous Holter ECG recording in patients with high cardiovascular risk and clinical palpitations: the prospective after study. Halimi F, Sabouret P, Huberman JP, Ouazana L, Guedj D, Djouadi K, Dhanjal TS, Goette A, Lafont C, Lellouche N.Clin Res Cardiol. 2022 Sep 28. doi: 10.1007/s00392-022-02109-9. Online ahead of print.PMID: 36169720

[Atrial fibrillation on the intensive care unit : The special prognostic importance of the first manifestation]. Goette A, Brandner S.Herzschrittmacherther Elektrophysiol. 2022 Dec;33(4):391-397. doi: 10.1007/s00399-022-00899-z. Epub 2022 Sep 26.PMID: 36156739 Review. German.

Attaining sinus rhythm mediates improved outcome with early rhythm control therapy of atrial fibrillation: the EAST-AFNET 4 trial. Eckardt L, Sehner S, Suling A, Borof K, Breithardt G, Crijns H, Goette A, Wegscheider K, Zapf A, Camm J, Metzner A, Kirchhof P.Eur Heart J. 2022 Oct 21;43(40):4127-4144. doi: 10.1093/eurheartj/ehac471.PMID: 36036648 

Early Rhythm Control in Patients With Atrial Fibrillation and High Comorbidity Burden. Rillig A, Borof K, Breithardt G, Camm AJ, Crijns HJGM, Goette A, Kuck KH, Metzner A, Vardas P, Vettorazzi E, Wegscheider K, Zapf A, Kirchhof P.Circulation. 2022 Sep 13;146(11):836-847. doi: 10.1161/CIRCULATIONAHA.122.060274. Epub 2022 Aug 15.PMID: 35968706 

Great Debate: Triple antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting should be limited to 1 week. De Caterina R, Agewall S, Andreotti F, Angiolillo DJ, Bhatt DL, Byrne RA, Collet JP, Eikelboom J, Fanaroff AC, Gibson CM, Goette A, Hindricks G, Lip GYH, Potpara T, Thiele H, Lopes RD, Galli M.Eur Heart J. 2022 Oct 7;43(37):3512-3527. doi: 10.1093/eurheartj/ehac294.PMID: 35925556 

Early diagnosis and better rhythm management to improve outcomes in patients with atrial fibrillation: the 8th AFNET/EHRA consensus conference. Schnabel RB, Marinelli EA, Arbelo E, Boriani G, Boveda S, Buckley CM, Camm AJ, Casadei B, Chua W, Dagres N, de Melis M, Desteghe L, Diederichsen SZ, Duncker D, Eckardt L, Eisert C, Engler D, Fabritz L, Freedman B, Gillet L, Goette A, Guasch E, Svendsen JH, Hatem SN, Haeusler KG, Healey JS, Heidbuchel H, Hindricks G, Hobbs FDR, Hübner T, Kotecha D, Krekler M, Leclercq C, Lewalter T, Lin H, Linz D, Lip GYH, Løchen ML, Lucassen W, Malaczynska-Rajpold K, Massberg S, Merino JL, Meyer R, Mont L, Myers MC, Neubeck L, Niiranen T, Oeff M, Oldgren J, Potpara TS, Psaroudakis G, Pürerfellner H, Ravens U, Rienstra M, Rivard L, Scherr D, Schotten U, Shah D, Sinner MF, Smolnik R, Steinbeck G, Steven D, Svennberg E, Thomas D, True Hills M, van Gelder IC, Vardar B, Palà E, Wakili R, Wegscheider K, Wieloch M, Willems S, Witt H, Ziegler A, Daniel Zink M, Kirchhof P.Europace. 2022 Jul 27:euac062. doi: 10.1093/europace/euac062.

Anti-inflammatory effects of endothelin receptor blockade in left atrial tissue of spontaneously hypertensive rats. Bukowska A, Nikonova Y, Wolke C, Lendeckel U, Kockskämper J, Goette A.Int J Cardiol Heart Vasc. 2022 Jul 20;42:101088. doi: 10.1016/j.ijcha.2022.101088. eCollection 2022 Oct.PMID: 35879971 

Presenting Pattern of Atrial Fibrillation and Outcomes of Early Rhythm Control Therapy. Goette A, Borof K, Breithardt G, Camm AJ, Crijns HJGM, Kuck KH, Wegscheider K, Kirchhof P; EAST-AFNET 4 Investigators.J Am Coll Cardiol. 2022 Jul 26;80(4):283-295. doi: 10.1016/j.jacc.2022.04.058.PMID: 35863844 

Successful catheter ablation of a left posterolateral accessory bypass tract and periinterventional management in a patient with MELAS syndrome. Goette A, Brandner S, Wojcik MJ, Berger C, Hammwöhner M.Herzschrittmacherther Elektrophysiol. 2022 Sep;33(3):330-333. doi: 10.1007/s00399-022-00881-9. Epub 2022 Jul 8.PMID: 35804205 

[Simulators and simulator training in interventional electrophysiology]. Goette A, Rickert V, Brandner S.Herzschrittmacherther Elektrophysiol. 2022 Sep;33(3):351-354. doi: 10.1007/s00399-022-00882-8. Epub 2022 Jul 8.PMID: 35804204 German.

How to use digital devices to detect and manage arrhythmias: an EHRA practical guide. Svennberg E, Tjong F, Goette A, Akoum N, Di Biase L, Bordachar P, Boriani G, Burri H, Conte G, Deharo JC, Deneke T, Drossart I, Duncker D, Han JK, Heidbuchel H, Jais P, de Oliviera Figueiredo MJ, Linz D, Lip GYH, Malaczynska-Rajpold K, Márquez M, Ploem C, Soejima K, Stiles MK, Wierda E, Vernooy K, Leclercq C, Meyer C, Pisani C, Pak HN, Gupta D, Pürerfellner H, Crijns HJGM, Chavez EA, Willems S, Waldmann V, Dekker L, Wan E, Kavoor P, Turagam MK, Sinner M.Europace. 2022 Jul 15;24(6):979-1005. doi: 10.1093/europace/euac038.PMID: 35368065 

AIM-AF: A Physician Survey in the United States and Europe. Camm AJ, Blomström-Lundqvist C, Boriani G, Goette A, Kowey PR, Merino JL, Piccini JP, Saksena S, Reiffel JA.J Am Heart Assoc. 2022 Mar 15;11(6):e023838. doi: 10.1161/JAHA.121.023838. Epub 2022 Mar 4.PMID: 35243874 

Corrigendum to: Anticoagulation, therapy of concomitant conditions, and early rhythm control therapy: a detailed analysis of treatment patterns in the EAST-AFNET 4 trial.Metzner A, Suling A, Brandes A, Breithardt G, Camm AJ, Crijns HJGM, Eckardt L, Elvan A, Goette A, Haegeli LM, Heidbuchel H, Kautzner J, Kuck KH, Mont L, Ng GA, Szumowski L, Themistoclakis S, van Gelder IC, Vardas P, Wegscheider K, Willems S, Kirchhof P.Europace. 2022 Apr 5;24(4):564. doi: 10.1093/europace/euab277.PMID: 34897422 

Pathophysiological differences between atrial fibrillation subgoups: Is there a fibrillatory-induced atherosclerotic disease progression?

Goette A.Int J Cardiol Heart Vasc. 2021 Oct 28;37:100892. doi: 10.1016/j.ijcha.2021.100892. eCollection 2021 Dec.PMID: 34761099 

Atrial Cardiomyopathy: Pathophysiology and Clinical Consequences.Goette A, Lendeckel U.Cells. 2021 Sep 30;10(10):2605. doi: 10.3390/cells10102605.PMID: 34685585 

 

Anticoagulation, therapy of concomitant conditions, and early rhythm control therapy: a detailed analysis of treatment patterns in the EAST - AFNET 4 trial. Metzner A, Suling A, Brandes A, Breithardt G, Camm AJ, Crijns HJGM, Eckardt L, Elvan A, Goette A, Haegeli LM, Heidbuchel H, Kautzner J, Kuck KH, Mont L, Ng GA, Szumowski L, Themistoclakis S, van Gelder IC, Vardas P, Wegscheider K, Willems S, Kirchhof P.Europace. 2022 Apr 5;24(4):552-564. doi: 10.1093/europace/euab200.PMID: 34473249 

 

Systematic, early rhythm control strategy for atrial fibrillation in patients with or without symptoms: the EAST-AFNET 4 trial. Willems S, Borof K, Brandes A, Breithardt G, Camm AJ, Crijns HJGM, Eckardt L, Gessler N, Goette A, Haegeli LM, Heidbuchel H, Kautzner J, Ng GA, Schnabel RB, Suling A, Szumowski L, Themistoclakis S, Vardas P, van Gelder IC, Wegscheider K, Kirchhof P.Eur Heart J. 2022 Mar 21;43(12):1219-1230. doi: 10.1093/eurheartj/ehab593.PMID: 34447995

Corrigendum to: Anticoagulation, therapy of concomitant conditions, and early rhythm control therapy: a detailed analysis of treatment patterns in the EAST-AFNET 4 trial. Metzner A, Suling A, Brandes A, Breithardt G, Camm AJ, Crijns HJGM, Eckardt L, Elvan A, Goette A, Haegeli LM, Heidbuchel H, Kautzner J, Kuck KH, Mont L, Ng GA, Szumowski L, Themistoclakis S, van Gelder IC, Vardas P, Wegscheider K, Willems S, Kirchhof P.Europace. 2021 Dec 13:euab277. doi: 10.1093/europace/euab277. Online ahead of print.PMID: 34897422 

 

Pathophysiological differences between atrial fibrillation subgoups: Is there a fibrillatory-induced atherosclerotic disease progression? Goette A.Int J Cardiol Heart Vasc. 2021 Oct 28;37:100892. doi: 10.1016/j.ijcha.2021.100892. eCollection 2021 Dec.PMID: 34761099 

Atrial Cardiomyopathy: Pathophysiology and Clinical Consequences. Goette A, Lendeckel U.Cells. 2021 Sep 30;10(10):2605. doi: 10.3390/cells10102605.PMID: 34685585 

Anticoagulation, therapy of concomitant conditions, and early rhythm control therapy: a detailed analysis of treatment patterns in the EAST - AFNET 4 trial. Metzner A, Suling A, Brandes A, Breithardt G, Camm AJ, Crijns HJGM, Eckardt L, Elvan A, Goette A, Haegeli LM, Heidbuchel H, Kautzner J, Kuck KH, Mont L, Ng AA, Szumowski L, Themistoclakis S, van Gelder IC, Vardas P, Wegscheider K, Willems S, Kirchhof P.Europace. 2021 Sep 2:euab200. doi: 10.1093/europace/euab200. Online ahead of print.PMID: 34473249

Systematic, early rhythm control strategy for atrial fibrillation in patients with or without symptoms: the EAST-AFNET 4 trial.Willems S, Borof K, Brandes A, Breithardt G, Camm AJ, Crijns HJGM, Eckardt L, Gessler N, Goette A, Haegeli LM, Heidbuchel H, Kautzner J, Ng GA, Schnabel RB, Suling A, Szumowski L, Themistoclakis S, Vardas P, van Gelder IC, Wegscheider K, Kirchhof P.Eur Heart J. 2021 Aug 27:ehab593. doi: 10.1093/eurheartj/ehab593. Online ahead of print.PMID: 34447995

Early Rhythm Control Therapy in Patients With Atrial Fibrillation and Heart Failure. Rillig A, Magnussen C, Ozga AK, Suling A, Brandes A, Breithardt G, Camm AJ, Crijns HJGM, Eckardt L, Elvan A, Goette A, Gulizia M, Haegeli L, Heidbuchel H, Kuck KH, Ng A, Szumowski L, van Gelder I, Wegscheider K, Kirchhof P.Circulation. 2021 Sep 14;144(11):845-858. doi: 10.1161/CIRCULATIONAHA.121.056323. Epub 2021 Jul 30.PMID: 34328366 Free PMC article.

Cost-Effectiveness Analyses of an Absorbable Antibacterial Envelope for Use in Patients at Increased Risk of Cardiac Implantable Electronic Device Infection in Germany, Italy, and England. Boriani G, Kennergren C, Tarakji KG, Wright DJ, Ahmed FZ, McComb JM, Goette A, Blum T, Biffi M, Green M, Shore J, Carion PL, Wilkoff BL.Value Health. 2021 Jul;24(7):930-938. doi: 10.1016/j.jval.2020.12.021. Epub 2021 Apr 1.PMID: 34243836 

Is left atrial strain the pathophysiological link between transplanted stem cells and atrial fibrillation? Goette A.Int J Cardiol. 2021 Sep 15;339:60-61. doi: 10.1016/j.ijcard.2021.06.044. Epub 2021 Jun 30.PMID: 34214503 

Infections of cardiac implantable electronic devices: still a cause of high mortality. Goette A, Sommer P.Europace. 2021 Jun 23;23(23 Suppl 4):iv1-iv2. doi: 10.1093/europace/euab139.PMID: 34160598 

Expert opinion paper on cardiac imaging after ischemic stroke. Schnabel RB, Camen S, Knebel F, Hagendorff A, Bavendiek U, Böhm M, Doehner W, Endres M, Gröschel K, Goette A, Huttner HB, Jensen C, Kirchhof P, Korosoglou G, Laufs U, Liman J, Morbach C, Nabavi DG, Neumann-Haefelin T, Pfeilschifter W, Poli S, Rizos T, Rolf A, Röther J, Schäbitz WR, Steiner T, Thomalla G, Wachter R, Haeusler KG.Clin Res Cardiol. 2021 Jul;110(7):938-958. doi: 10.1007/s00392-021-01834-x. Epub 2021 Jun 18.PMID: 34143285

[Interdisciplinary aspects of oral anticoagulation with NOACs in atrial fibrillation]. Dürschmied D, Goette A, Hardt R, Kleinschnitz C, Kämmerer W, Lembens C, Schmitt W, Bode C.Dtsch Med Wochenschr. 2021 May;146(S 01):S2-S16. doi: 10.1055/a-1472-3188. Epub 2021 May 6.PMID: 33957679 German.

Use of healthcare claims to validate the Prevention of Arrhythmia Device Infection Trial cardiac implantable electronic device infection risk score. Ahmed FZ, Blomström-Lundqvist C, Bloom H, Cooper C, Ellis C, Goette A, Greenspon AJ, Love CJ, Johansen JB, Philippon F, Tarakji KG, Holbrook R, Sherfesee L, Xia Y, Seshadri S, Lexcen DR, Krahn AD.Europace. 2021 Sep 8;23(9):1446-1455. doi: 10.1093/europace/euab028.PMID: 33755136

 

Does Extensive Left Atrial Ablation in Atrial Fibrillation Patients Increase the Risk of Embolic Stroke? Goette A.JACC Clin Electrophysiol. 2021 Mar;7(3):319-320. doi: 10.1016/j.jacep.2020.12.002.

Dynamic risk assessment to improve quality of care in patients with atrial fibrillation: the 7th AFNET/EHRA Consensus Conference. Fabritz L, Crijns HJGM, Guasch E, Goette A, Häusler KG, Kotecha D, Lewalter T, Meyer C, Potpara TS, Rienstra M, Schnabel RB, Willems S, Breithardt G, Camm AJ, Chan A, Chua W, de Melis M, Dimopoulou C, Dobrev D, Easter C, Eckardt L, Haase D, Hatem S, Healey JS, Heijman J, Hohnloser SH, Huebner T, Ilyas BS, Isaacs A, Kutschka I, Leclercq C, Lip GYH, Marinelli EA, Merino JL, Mont L, Nabauer M, Oldgren J, Pürerfellner H, Ravens U, Savelieva I, Sinner MF, Sitch A, Smolnik R, Steffel J, Stein K, Stoll M, Svennberg E, Thomas D, Van Gelder IC, Vardar B, Wakili R, Wieloch M, Zeemering S, Ziegler PD, Heidbuchel H, Hindricks G, Schotten U, Kirchhof P.Europace. 2021 Jan 12:euaa279. doi: 10.1093/europace/euaa279. Online ahead of print.PMID: 33555020

Ten years of non-vitamin K antagonists oral anticoagulants for stroke prevention in atrial fibrillation: is warfarin obsolete? Hammwöhner M, Goette A.Eur Heart J Suppl. 2020 Dec 22;22(Suppl O):O28-O41. doi: 10.1093/eurheartj/suaa177. eCollection 2020 Dec.PMID: 33380942 

 

Pathophysiological consequences of the EAST-AFNET4 trial: AF is not an innocent bystander. Goette A. Cardiovasc Res. 2020 Dec 1;116(14):e200-e201. doi: 10.1093/cvr/cvaa295.PMID: 33205206 

 

Safety and efficacy of double versus triple antithrombotic therapy in patients with atrial fibrillation with or without acute coronary syndrome undergoing percutaneous coronary intervention: a collaborative meta-analysis of NOAC-based randomized clinical trials. Gargiulo G, Cannon CP, Gibson CM, Goette A, Lopes RD, Oldgren J, Korjian S, Windecker S, Esposito G, Vranckx P, Valgimigli M.Eur Heart J Cardiovasc Pharmacother. 2020 Oct 29:pvaa116. doi: 10.1093/ehjcvp/pvaa116. Online ahead of print.PMID: 33119069

 

Clinical risk predictors in atrial fibrillation patients following successful coronary stenting: ENTRUST-AF PCI sub-analysis. Goette A, Eckardt L, Valgimigli M, Lewalter T, Laeis P, Reimitz PE, Smolnik R, Zierhut W, Tijssen JG, Vranckx P.Clin Res Cardiol. 2020 Oct 24. doi: 10.1007/s00392-020-01760-4. Online ahead of print.PMID: 33098470

 

Atrial fibrillation patients undergoing percutaneous coronary intervention: dual or triple antithrombotic therapy with non-vitamin K antagonist oral anticoagulants. Goette A, Vranckx P.Eur Heart J Suppl. 2020 Sep 15;22(Suppl I):I22-I31. doi: 10.1093/eurheart/suaa101. eCollection 2020 Sep.PMID: 33088231 

 

COVID-19-Induced Cytokine Release Syndrome Associated with Pulmonary Vein Thromboses, Atrial Cardiomyopathy, and Arterial Intima Inflammation. Goette A, Patscheke M, Henschke F, Hammwöhner M.TH Open. 2020 Sep 26;4(3):e271-e279. doi: 10.1055/s-0040-1716717. eCollection 2020 Jul.PMID: 32995705 

 

 Psychological aspects of atrial fibrillation: A systematic narrative review : Impact on incidence, cognition, prognosis, and symptom perception.

 

Ladwig KH, Goette A, Atasoy S, Johar H.Curr Cardiol Rep. 2020 Sep 10;22(11):137. doi: 10.1007/s11886-020-01396-w.PMID: 32910300 

 Early Rhythm-Control Therapy in Patients with Atrial Fibrillation. Kirchhof P, Camm AJ, Goette A, Brandes A, Eckardt L, Elvan A, Fetsch T, van Gelder IC, Haase D, Haegeli LM, Hamann F, Heidbüchel H, Hindricks G, Kautzner J, Kuck KH, Mont L, Ng GA, Rekosz J, Schoen N, Schotten U, Suling A, Taggeselle J, Themistoclakis S, Vettorazzi E, Vardas P, Wegscheider K, Willems S, Crijns HJGM, Breithardt G; EAST-AFNET 4 Trial Investigators.N Engl J Med. 2020 Oct 1;383(14):1305-1316. doi: 10.1056/NEJMoa2019422. Epub 2020 Aug 29.PMID: 32865375 Clinical Trial.

 

 Edoxaban in atrial fibrillation patients with percutaneous coronary intervention by acute or chronic coronary syndrome presentation: a pre-specified analysis of the ENTRUST-AF PCI trial.

 

Vranckx P, Valgimigli M, Eckardt L, Lewalter T, Unikas R, Marin F, Schiele F, Laeis P, Reimitz PE, Smolnik R, Zierhut W, Tijssen J, Goette A.Eur Heart J. 2020 Dec 14;41(47):4497-4504. doi: 10.1093/eurheartj/ehaa617.PMID: 32860041 

 Safety and Efficacy of Double Antithrombotic Therapy With Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis. Capodanno D, Di Maio M, Greco A, Bhatt DL, Gibson CM, Goette A, Lopes RD, Mehran R, Vranckx P, Angiolillo DJ.J Am Heart Assoc. 2020 Aug 18;9(16):e017212. doi: 10.1161/JAHA.120.017212. Epub 2020 Aug 1.PMID: 32805186 

 

Differences in Thromboembolic Complications Between Paroxysmal and Persistent Atrial Fibrillation Patients Following Electrical Cardioversion (From the ENSURE-AF Study).

 

Goette A, Lip GYH, Jin J, Heidbuchel H, Cohen AA, Ezekowitz M, Merino JL.Am J Cardiol. 2020 Sep 15;131:27-32. doi: 10.1016/j.amjcard.2020.06.046. Epub 2020 Jun 30.PMID: 32753268 Clinical Trial.

Assessment of OMT-28, a synthetic analog of omega-3 epoxyeicosanoids, in patients with persistent atrial fibrillation: Rationale and design of the PROMISE-AF phase II study. Berlin S, Goette A, Summo L, Lossie J, Gebauer A, Al-Saady N, Calo L, Naccarelli G, Schunck WH, Fischer R, Camm AJ, Dobrev D.Int J Cardiol Heart Vasc. 2020 Jul 10;29:100573. doi: 10.1016/j.ijcha.2020.100573. eCollection 2020 Aug.PMID: 32685659 

 

 Atrial functional mitral regurgitation: A relavant factor for fibrillatory atrial cardiomyopathy prognosis?

 

Goette A.Int J Cardiol. 2020 Oct 1;316:203-204. doi: 10.1016/j.ijcard.2020.07.012. Epub 2020 Jul 16.PMID: 32682007 

Clinical factors related to successful or unsuccessful cardioversion in the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE-AF) randomized trial.

 

 

Lip GYH, Merino JL, Banach M, Al-Saady N, Jin J, Melino M, Winters SM, Kozieł M, Goette A.J Arrhythm. 2020 Apr 15;36(3):430-438. doi: 10.1002/joa3.12341. eCollection 2020 Jun.PMID: 32528568 

Commentary: Temporarily omitting oral anticoagulants early after stenting for acute coronary syndromes patients with atrial fibrillation.
Limbruno U, Goette A, De Caterina R. Int J Cardiol. 2020 May 7:S0167-5273(20)32667-X. doi: 10.1016/j.ijcard.2020.05.024. Online ahead of print.Int J Cardiol. 2020. PMID: 32389765
 
Effect of concomitant antiplatelet agents on clinical outcomes in the edoxaban vs warfarin in subjects undergoing cardioversion of atrial fibrillation (ENSURE-AF) randomized trial. Goette A, Merino JL, De Caterina R, Huber K, Heidbuchel H, Jin J, Lip GYH. Clin Res Cardiol. 2020 Mar 31. doi: 10.1007/s00392-020-01635-8. Online ahead of print.Clin Res Cardiol. 2020. PMID: 32236718
 
Paroxysmal and persistent atrial fibrillation ablation outcomes with the pulmonary vein ablation catheter GOLD duty-cycled phased radiofrequency ablation catheter: quality of life and 12-month efficacy results from the GOLD Atrial Fibrillation Registry.
Boersma L, Koźluk E, Maglia G, de Sousa J, Grebe O, Eckardt L, Hokanson RB, Hemingway LA, Ostern E, Park HS, Rovaris G, Arribas F, Scharf C, Csanádi Z, Arenal Á, Laurenzi F, Klaver M, Goette A Europace. 2020 Mar 27:euaa042. doi: 10.1093/europace/euaa042. Online ahead of print. Europace. 2020. PMID: 32219388
 
Antithrombotic treatment strategies after PCI - Authors' reply. Vranckx P, Valgimigli M, Eckardt L, Gargiulo G, Goette A. Lancet. 2020 Mar 14;395(10227):867-868. doi: 10.1016/S0140-6736(20)30033-7.Lancet. 2020. PMID: 32171407
 
Comparing TEE- vs Non-TEE-guided cardioversion of atrial fibrillation: The ENSURE-AF trial. Kozieł M, Merino JL, De Caterina R, Huber K, Jin J, Melino M, Goette A, Lip GYH; ENSURE-AF Investigators. Eur J Clin Invest. 2020 Mar 9:e13221. doi: 10.1111/eci.13221. Online ahead of print.Eur J Clin Invest. 2020. PMID: 32150758
 
Optimal Antithrombotic Regimen for Patients With Atrial Fibrillation Undergoing Percutaneous Coronary Intervention: An Updated Network Meta-analysis.
Lopes RD, Hong H, Harskamp RE, Bhatt DL, Mehran R, Cannon CP, Granger CB, Verheugt FWA, Li J, Ten Berg JM, Sarafoff N, Vranckx P, Goette A, Gibson CM, Alexander JH. JAMA Cardiol. 2020 Feb 26. doi: 10.1001/jamacardio.2019.6175. Online ahead of print.JAMA Cardiol. 2020. PMID: 32101251
 
Higher risk of stent thrombosis with double therapy with direct oral anticoagulants: cherry picking the populations of interest does not help. Gargiulo G, Goette A, Vranckx P, Valgimigli M. Eur Heart J. 2020 May 1;41(17):1701-1702. doi: 10.1093/eurheartj/ehaa076.Eur Heart J. 2020. PMID: 32060541 Free PMC article.
 
Antithrombotic therapy after coronary artery stenting in atrial fibrillation: dual therapy encompassing NOAC plus P2Y12 inhibitor is ready for prime time! Goette A. Ann Transl Med. 2019 Dec;7(Suppl 8):S270. doi: 10.21037/atm.2019.12.33.Ann Transl Med. 2019. PMID: 32015989
 
Edoxaban versus warfarin in vitamin K antagonist experienced and naïve patients from the edoxaban versus warfarin in subjects undergoing cardioversion of atrial fibrillation (ENSURE-AF) randomised trial. Kozieł M, Al-Saady N, Hjortshøj SP, Goudev A, Huber K, Cohen A, Jin J, Melino M, Winters SM, Goette A, Lip GYH. Clin Res Cardiol. 2020 Jan 8. doi: 10.1007/s00392-019-01594-9. Online ahead of print.Clin Res Cardiol. 2020. PMID: 31915996

Activated clotting factor X mediates mitochondrial alterations and inflammatory responses via protease-activated receptor signaling in alveolar epithelial cells. Bukowska A, Schild L, Bornfleth P, Peter D, Wiese-Rischke C, Gardemann A, Isermann B, Walles T, Goette A. Eur J Pharmacol. 2020 Feb 15;869:172875. doi: 10.1016/j.ejphar.2019.172875. Epub 2019 Dec 23.Eur J Pharmacol. 2020. PMID: 31877279
 
Cabins, castles, and constant hearts: rhythm control therapy in patients with atrial fibrillation. Willems S, Meyer C, de Bono J, Brandes A, Eckardt L, Elvan A, van Gelder I, Goette A, Gulizia M, Haegeli L, Heidbuchel H, Haeusler KG, Kautzner J, Mont L, Ng GA, Szumowski L, Themistoclakis S, Wegscheider K, Kirchhof. Eur Heart J. 2019 Dec 7;40(46):3793-3799c. doi: 10.1093/eurheartj/ehz782.Eur Heart J. 2019. PMID: 31755940

'Real-world' observational studies in arrhythmia research: data sources, methodology, and interpretation. A position document from European Heart Rhythm Association (EHRA), endorsed by Heart Rhythm Society (HRS), Asia-Pacific HRS (APHRS), and Latin America HRS (LAHRS). Torp-Pedersen C, et al. Europace. 2019

Safety and efficacy outcomes of double vs. triple antithrombotic therapy in patients with atrial fibrillation following percutaneous coronary intervention: a systematic review and meta-analysis of non-vitamin K antagonist oral anticoagulant-based randomized clinical trials. Gargiulo G, et al. Eur Heart J. 2019

Edoxaban-based versus vitamin K antagonist-based antithrombotic regimen after successful coronary stenting in patients with atrial fibrillation (ENTRUST-AF PCI): a randomised, open-label, phase 3b trial. Randomized controlled trial. Vranckx P, et al. Lancet. 2019

Determinants of left atrium thrombi in scheduled cardioversion: an ENSURE-AF study analysis. Merino JL, et al. Europace. 2019

Atrial high-rate episodes: prevalence, stroke risk, implications for management, and clinical gaps in evidence. Bertaglia E, et al. Europace. 2019

Safety and efficacy of dronedarone from clinical trials to real-world evidence: implications for its use in atrial fibrillation. Boriani G, et al. Europace. 2019

Age-related regulation and region-specific distribution of ion channel subunits promoting atrial fibrillation in human left and right atria. Biliczki P, et al. Europace. 2019

Atrial cardiomyopathy: Answer to Letter to the Editor by Dr. O. Jolobe. Goette A, et al. Int J Cardiol. 2019

EHRA White Paper: knowledge gaps in arrhythmia management-status 2019. Goette A, et al. Europace. 2019

[Rhythmogenic syncopes and survived sudden cardiac death]. Boxhammer E, et al. Herzschrittmacherther Elektrophysiol. 2019. Article in German.

Cardiac contractility modulation improves long-term survival and hospitalizations in heart failure with reduced ejection fraction.Anker SD, et al. Eur J Heart Fail. 2019

Spontaneous conversion in patients with non-valvular atrial fibrillation planned for electrical cardioversion: A subanalysis of the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion Of Atrial Fibrillation (ENSURE-AF) trial. Cohen AA, et al. Am Heart J. 2019

Impact of dronedarone on the risk of myocardial infarction and stroke in atrial fibrillation patients followed in general practices in Germany. Ehrlich JR, et al. Int J Cardiol. 2019

Clinical importance of atrial cardiomyopathy. Hammwöhner M, et al. Int J Cardiol. 2019

Impact of Body Mass Index on Outcomes in the Edoxaban Versus Warfarin Therapy Groups in Patients Underwent Cardioversion of Atrial Fibrillation (from ENSURE-AF). Lip GYH, et al. Am J Cardiol. 2019

German Cardiac Society Working Group on Cellular Electrophysiology state-of-the-art paper: impact of molecular mechanisms on clinical arrhythmia management. Thomas D, et al. Clin Res Cardiol. 2019

Impact of dronedarone on the risk of myocardial infarction and stroke in atrial fibrillation patients followed in general practices in Germany. Ehrlich JR, Look C, Kostev K, Israel CW, Goette A. Int J Cardiol. 2018 Dec 1. pii: S0167-5273(18)34728-4. doi: 10.1016/j.ijcard.2018.11.133. [Epub ahead of print

Clinical importance of atrial cardiomyopathy. Hammwöhner M, Bukowska A, Mahardika W, Goette A. Int J Cardiol. 2018 Nov 28. pii: S0167-5273(18)32175-2. doi: 10.1016/j.ijcard.2018.11.121. [Epub ahead of print] Review.

Impact of Body Mass Index on Outcomes in the Edoxaban Versus Warfarin Therapy Groups in Patients Underwent Cardioversion of Atrial Fibrillation (from ENSURE-AF). Lip GYH, Merino JL, Banach M, de Groot JR, Maier LS, Themistoclakis S, Boriani G, Jin J, Melino M, Winters SM, Goette A. Am J Cardiol. 2018 Nov 24. pii: S0002-9149(18)32100-3. doi: 10.1016/j.amjcard.2018.11.019. [Epub ahead of print]

German Cardiac Society Working Group on Cellular Electrophysiology state-of-the-art paper: impact of molecular mechanisms on clinical arrhythmia management. Thomas D, Christ T, Fabritz L, Goette A, Hammwöhner M, Heijman J, Kockskämper J, Linz D, Odening KE, Schweizer PA, Wakili R, Voigt N. Clin Res Cardiol. 2018 Oct 10. doi: 10.1007/s00392-018-1377-1. [Epub ahead of print] Review.

 

Integration of "omics" techniques: Dronedarone affects cardiac remodeling in the infarction border zone. Chilukoti RK, Lendeckel J, Darm K, Bukowska A, Goette A, Sühling M, Utpatel K, Peters B, Homuth G, Völker U, Wolke C, Scharf C, Lendeckel U.

Exp Biol Med (Maywood). 2018 Jul;243(11):895-910. doi: 10.1177/1535370218788517.

Edoxaban therapy increases treatment satisfaction and reduces utilization of healthcare resources: an analysis from the EdoxabaN vs. warfarin in subjectS UndeRgoing cardiovErsion of atrial fibrillation (ENSURE-AF) study. Goette A, Kwong WJ, Ezekowitz MD, Banach M, Hjortshoj SP, Zamoryakhin D, Lip GYH. Europace. 2018 Dec 1;20(12):1936-1943. doi: 10.1093/europace/euy141.

Uninterrupted NOAC therapy in patients undergoing catheter ablation of atrial fibrillation: "Dual anticoagulant therapy" ready for primetime or systematic overtreatment? Goette A. Int J Cardiol. 2018 Nov 1;270:185-186. doi: 10.1016/j.ijcard.2018.06.043. Epub 2018 Jun 13. No abstract available.

European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: What is the best practice? Dagres N, Chao TF, Fenelon G, Aguinaga L, Benhayon D, Benjamin EJ, Bunch TJ, Chen LY, Chen SA, Darrieux F, de Paola A, Fauchier L, Goette A, Kalman J, Kalra L, Kim YH, Lane DA, Lip GYH, Lubitz SA, Márquez MF, Potpara T, Pozzer DL, Ruskin JN, Savelieva I, Teo WS, Tse HF, Verma A, Zhang S, Chung MK, Bautista-Vargas WF, Chiang CE, Cuesta A, Dan GA, Frankel DS, Guo Y, Hatala R, Lee YS, Murakawa Y, Pellegrini CN, Pinho C, Milan DJ, Morin DP, Nadalin E, Ntaios G, Prabhu MA, Proietti M, Rivard L, Valentino M, Shantsila A. J Arrhythm. 2018 Mar 23;34(2):99-123. doi: 10.1002/joa3.12050. eCollection 2018 Apr. No abstract available.

European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: what is the best practice? Dagres N, Chao TF, Fenelon G, Aguinaga L, Benhayon D, Benjamin EJ, Bunch TJ, Chen LY, Chen SA, Darrieux F, de Paola A, Fauchier L, Goette A, Kalman J, Kalra L, Kim YH, Lane DA, Lip GYH, Lubitz SA, Márquez MF, Potpara T, Pozzer DL, Ruskin JN, Savelieva I, Teo WS, Tse HF, Verma A, Zhang S, Chung MK. Heart Rhythm. 2018 Jun;15(6):e37-e60. doi: 10.1016/j.hrthm.2018.03.005. Epub 2018 Mar 18. No abstract available.

The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: executive summary. Steffel J, Verhamme P, Potpara TS, Albaladejo P, Antz M, Desteghe L, Georg Haeusler K, Oldgren J, Reinecke H, Roldan-Schilling V, Rowell N, Sinnaeve P, Collins R, Camm AJ, Heidbüchel H; ESC Scientific Document Group . Europace. 2018 Mar 19. doi: 10.1093/europace/euy054. [Epub ahead of print]

European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: what is the best practice? Dagres N, Chao TF, Fenelon G, Aguinaga L, Benhayon D, Benjamin EJ, Bunch TJ, Chen LY, Chen SA, Darrieux F, de Paola A, Fauchier L, Goette A, Kalman J, Kalra L, Kim YH, Lane DA, Lip GYH, Lubitz SA, Márquez MF, Potpara T, Pozzer DL, Ruskin JN, Savelieva I, Teo WS, Tse HF, Verma A, Zhang S, Chung MK; ESC Scientific Document Group . Europace. 2018 Sep 1;20(9):1399-1421. doi: 10.1093/europace/euy046. No abstract available.

The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Steffel J, Verhamme P, Potpara TS, Albaladejo P, Antz M, Desteghe L, Haeusler KG, Oldgren J, Reinecke H, Roldan-Schilling V, Rowell N, Sinnaeve P, Collins R, Camm AJ, Heidbüchel H; ESC Scientific Document Group . Eur Heart J. 2018 Apr 21;39(16):1330-1393. doi: 10.1093/eurheartj/ehy136.

Evaluation of the safety and efficacy of an edoxaban-based antithrombotic regimen in patients with atrial fibrillation following successful percutaneous coronary intervention (PCI) with stent placement: Rationale and design of the ENTRUST-AF PCI trial. Vranckx P, Lewalter T, Valgimigli M, Tijssen JG, Reimitz PE, Eckardt L, Lanz HJ, Zierhut W, Smolnik R, Goette A. Am Heart J. 2018 Feb;196:105-112. doi: 10.1016/j.ahj.2017.10.009. Epub 2017 Oct 23.

Advances in cardiac cellular electrophysiology - Relevance for clinical translation. Ravens U, Goette A. Herzschrittmacherther Elektrophysiol.
2018 Jan 25. doi: 10.1007/s00399-018-0556-0. [Epub ahead of print] No abstract available.

Atrial fibrillation and stroke risk factors induce decline in creatinine clearance: Is there a specific "fibrillatory kidney disease"? Goette A. Int J Cardiol. 2018 Feb 15;253:82-83. doi: 10.1016/j.ijcard.2017.11.052.
No abstract available.

Integrating new approaches to atrial fibrillation management: the 6th AFNET/EHRA Consensus Conference. Kotecha D, Breithardt G, Camm AJ, Lip GYH, Schotten U, Ahlsson A, Arnar D, Atar D, Auricchio A, Bax J, Benussi S, Blomstrom-Lundqvist C, Borggrefe M, Boriani G, Brandes A, Calkins H,
Casadei B, Castellá M, Chua W, Crijns H, Dobrev D, Fabritz L, Feuring M, Freedman B, Gerth A, Goette A, Guasch E, Haase D, Hatem S, Haeusler KG, Heidbuchel H, Hendriks J, Hunter C, Kääb S, Kespohl S, Landmesser U, Lane DA, Lewalter T, Mont L, Nabauer M, Nielsen JC, Oeff M, Oldgren J, Oto A, Pison L, Potpara T, Ravens U, Richard-Lordereau I, Rienstra M, Savelieva I, Schnabel R, Sinner MF, Sommer P, Themistoclakis S, Van Gelder IC, Vardas PE, Verma A, Wakili R, Weber E, Werring D, Willems S,
Ziegler A, Hindricks G, Kirchhof P. Europace. 2018 Jan 2. doi:
10.1093/europace/eux318. [Epub ahead of print]

Atrial thrombogenesis in atrial fibrillation : Results from atrial fibrillation models and AF-patients. Bukowska A, Hammwöhner M, Corradi D, Mahardhika W, Goette A. Herzschrittmacherther Elektrophysiol. 2017 Dec 12. doi: 10.1007/s00399-017-0543-x. [Epub ahead of print] Review.

Progressive impairment of atrial myocyte function during left ventricular hypertrophy and heart failure. Pluteanu F, Nikonova Y, Holzapfel A, Herzog B, Scherer A, Preisenberger J, Pla?ki? J, Scheer K,
Ivanova T, Bukowska A, Goette A, Kockskämper J. J Mol Cell Cardiol. 2017
Dec 2;114:253-263. doi: 10.1016/j.yjmcc.2017.11.020. [Epub ahead of print]

Relation of Stroke and Bleeding Risk Profiles to Efficacy and Safety of Edoxaban for Cardioversion of Atrial Fibrillation (from the EdoxabaN versus warfarin in subjectS Undergoing cardiovErsion of Atrial
Fibrillation [ENSURE-AF] Study). Lip GYH, Merino JL, Dan GA, Themistoclakis S, Ellenbogen KA, De Caterina R, Goudev A, Jin J, Melino M, Winters SM, Goette A. Am J Cardiol. 2018 Jan 15;121(2):193-198. doi: 10.1016/j.amjcard.2017.10.008. Epub 2017 Nov 20.

Incidence and costs of cardiac device infections: retrospective analysis using German health claims data. Ludwig S, Theis C, Brown B, Witthohn A, Lux W, Goette A. J Comp Eff Res. 2017 Nov 14. doi:
10.2217/cer-2017-0080. [Epub ahead of print]

The relationship of renal function to outcome: A post hoc analysis from the EdoxabaN versus warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE-AF) study. Lip GYH, Al-Saady N, Ezekowitz MD, Banach M, Goette A. Am Heart J. 2017 Nov;193:16-22. doi:
10.1016/j.ahj.2017.07.010. Epub 2017 Jul 20.

Occupational radiation exposure in the electrophysiology laboratory with a focus on personnel with reproductive potential and during pregnancy: A European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS). Sarkozy A, De Potter T, Heidbuchel H, Ernst S, Kosiuk J, Vano E, Picano E, Arbelo E, Tedrow U; ESC Scientific Document Group. Europace. 2017 Dec 1;19(12):1909-1922. doi: 10.1093/europace/eux252. No abstract available.

Why is there still undertreatment with oral anticoagulants in elderly high risk patients with AF? Goette A. Int J Cardiol. 2017 Dec 15;249:247-248. doi: 10.1016/j.ijcard.2017.08.034. No abstract
available.

Screening for atrial fibrillation: a European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLAECE). Mairesse GH, Moran P, Van Gelder IC, Elsner C, Rosenqvist M, Mant J, Banerjee A, Gorenek B, Brachmann J, Varma N, Glotz de Lima G, Kalman J, Claes N, Lobban T, Lane D, Lip GYH, Boriani G; ESC Scientific Document Group.
Europace. 2017 Oct 1;19(10):1589-1623. doi: 10.1093/europace/eux177. No abstract available.

Device-detected subclinical atrial tachyarrhythmias: definition, implications and management-an European Heart Rhythm Association (EHRA) consensus document, endorsed by Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS) and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE). Gorenek B Chair, Bax J, Boriani G, Chen SA, Dagres N, Glotzer TV, Healey JS, Israel CW, Kudaiberdieva G, Levin LÅ, Lip GYH, Martin D, Okumura K, Svendsen JH, Tse HF, Botto GL Co-Chair; ESC Scientific Document Group. Europace. 2017 Sep 1;19(9):1556-1578. doi: 10.1093/europace/eux163. No abstract available.

The safety of edoxaban for treating atrial fibrillation. Hammwöhner M, Goette A. Expert Opin Drug Saf. 2017 Nov;16(11):1295-1303. doi: 10.1080/14740338.2017.1372418. Epub 2017 Sep 18. Review

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.
Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, Fonseca F, Nicolau J, Koenig W, Anker SD, Kastelein JJP, Cornel JH, Pais P, Pella D, Genest J, Cifkova R, Lorenzatti A, Forster T, Kobalava Z, Vida-Simiti L, Flather M, Shimokawa H, Ogawa H, Dellborg M, Rossi PRF, Troquay RPT, Libby P, Glynn RJ; CANTOS Trial Group. N Engl J Med. 2017 Sep 21;377(12):1119-1131. doi: 10.1056/NEJMoa1707914. Epub 2017 Aug 27.

Practical Implementation of Anticoagulation Strategy for Patients Undergoing Cardioversion of Atrial Fibrillation. Goette A, Heidbuchel H. Arrhythm Electrophysiol Rev. 2017 Jun;6(2):50-54. doi:
10.15420/aer.2017:3:2.

CREM-transgene mice: An animal model of atrial fibrillation and thrombogenesis. Bukowska A, Felgendreher M, Scholz B, Wolke C, Schulte JS, Fehrmann E, Wardelmann E, Seidl MD, Lendeckel U, Himmler K, Gardemann A, Goette A, Müller FU. Thromb Res. 2017 Aug 1. pii: S0049-3848(17)30443-7. doi: 10.1016/j.thromres.2017.07.033. [Epub ahead of print]

Probing oral anticoagulation in patients with atrial high rate episodes: Rationale and design of the Non-vitamin K antagonist Oral anticoagulants in patients with Atrial High rate episodes (NOAH-AFNET 6) trial.
Kirchhof P, Blank BF, Calvert M, Camm AJ, Chlouverakis G, Diener HC, Goette A, Huening A, Lip GYH, Simantirakis E, Vardas P. Am Heart J. 2017 Aug;190:12-18. doi: 10.1016/j.ahj.2017.04.015. Epub 2017 May 3.

Anticoagulation Control in Warfarin-Treated Patients Undergoing Cardioversion of Atrial Fibrillation (from the Edoxaban Versus Enoxaparin-Warfarin in Patients Undergoing Cardioversion of Atrial Fibrillation Trial). Lip GYH, Al-Saady N, Jin J, Sun M, Melino M, Winters SM, Zamoryakhin D, Goette A. Am J Cardiol. 2017 Sep 1;120(5):792-796. doi: 10.1016/j.amjcard.2017.06.005. Epub 2017 Jun 15.

Protective regulation of the ACE2/ACE gene expression by estrogen in human atrial tissue from elderly men. Bukowska A, Spiller L, Wolke C, Lendeckel U, Weinert S, Hoffmann J, Bornfleth P, Kutschka I, Gardemann A, Isermann B, Goette A. Exp Biol Med (Maywood). 2017 Aug;242(14):1412-1423. doi: 10.1177/1535370217718808. Epub 2017 Jun 29.

European Heart Rhythm Association (EHRA)/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society (APHRS). Gorenek B, Pelliccia A, Benjamin EJ, Boriani G, Crijns HJ, Fogel RI, Van Gelder IC, Halle M, Kudaiberdieva G, Lane DA, Larsen TB, Lip GY, Løchen ML, Marín F, Niebauer J, Sanders P, Tokgozoglu L, Vos MA, Van Wagoner DR, Fauchier L, Savelieva I, Goette A, Agewall S, Chiang CE, Figueiredo M, Stiles M, Dickfeld T, Patton K, Piepoli M, Corra U, Marques-Vidal PM, Faggiano P, Schmid JP, Abreu A. Europace. 2017 Feb 1;19(2):190-225. doi:
10.1093/europace/euw242. No abstract available.

EHRA/HRS/APHRS/SOLAECE expert consensus on Atrial cardiomyopathies: definition, characterization, and clinical implication. Goette A, Kalman JM, Aguinaga L, Akar J, Cabrera JA, Chen SA, Chugh SS, Corradi D, D'Avila A, Dobrev D, Fenelon G, Gonzalez M, Hatem SN, Helm R, Hindricks G, Ho SY, Hoit B, Jalife J, Kim YH, Lip GY, Ma CS, Marcus GM, Murray K, Nogami A, Sanders P, Uribe W, Van Wagoner D, Nattel S; Document Reviewers:, Centurion OA, Kuck KH, Patton KK, Sapp JL, Stiles M, Svendsen JH, Upadhyay GA; Review coordinator:, Shantsila A. Europace. 2016 Jul 8. pii: euw161. [Epub ahead of print]
Predictors of sinus rhythm after electrical cardioversion of atrial fibrillation: results from a data mining project on the Flec-SL trial data set. Oto E, Okutucu S, Katircioglu-Öztürk D, Güvenir HA, Karaagaoglu E, Borggrefe M, Breithardt G, Goette A, Ravens U, Steinbeck G, Wegscheider K, Oto A, Kirchhof P. Europace. 2016 Jul 4. pii: euw144. [Epub ahead of print]

EHRA/HRS/APHRS/SOLAECE expert consensus on atrial cardiomyopathies: Definition, characterization, and clinical implication. Goette A, Kalman JM, Aguinaga L, Akar J, Cabrera JA, Chen SA, Chugh SS, Corradi D, D'Avila A, Dobrev D, Fenelon G, Gonzalez M, Hatem SN, Helm R, Hindricks G, Ho SY, Hoit B, Jalife J, Kim YH, Lip GY, Ma CS, Marcus GM, Murray K, Nogami A, Sanders P, Uribe W, Wagoner DV, Nattel S. Heart Rhythm. 2016 Jun 10. pii: S1547-5271(16)30376-9. doi: 10.1016/j.hrthm.2016.05.028. [Epub ahead of print]

[AFNET. A translational research network develops into an academic research organization]. Kirchhof P, Goette A, Näbauer M, Schotten U. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2016 Apr;59(4):514-22. doi: 10.1007/s00103-016-2323-x. German.

EACVI/EHRA Expert Consensus Document on the role of multi-modality imaging for the evaluation of patients with atrial fibrillation. Donal E, Lip GY, Galderisi M, Goette A, Shah D, Marwan M, Lederlin M, Mondillo S, Edvardsen T, Sitges M, Grapsa J, Garbi M, Senior R, Gimelli A, Potpara TS, Van Gelder IC, Gorenek B, Mabo P, Lancellotti P, Kuck KH, Popescu BA, Hindricks G, Habib G, Cosyns B, Delgado V, Haugaa KH, Muraru D, Nieman K, Cohen A. Eur Heart J Cardiovasc Imaging. 2016 Apr;17(4):355-83. doi: 10.1093/ehjci/jev354. Epub 2016 Feb 9.

A roadmap to improve the quality of atrial fibrillation management: proceedings from the fifth Atrial Fibrillation Network/European Heart Rhythm Association consensus conference. Kirchhof P, Breithardt G, Bax J, Benninger G, Blomstrom-Lundqvist C, Boriani G, Brandes A, Brown H, Brueckmann M, Calkins H, Calvert M, Christoffels V, Crijns H, Dobrev D, Ellinor P, Fabritz L, Fetsch T, Freedman SB, Gerth A, Goette A, Guasch E, Hack G, Haegeli L, Hatem S, Haeusler KG, Heidbüchel H, Heinrich-Nols J, Hidden-Lucet F, Hindricks G, Juul-Möller S, Kääb S, Kappenberger L, Kespohl S, Kotecha D, Lane DA, Leute A, Lewalter T, Meyer R, Mont L, Münzel F, Nabauer M, Nielsen JC, Oeff M, Oldgren J, Oto A, Piccini JP, Pilmeyer A, Potpara T, Ravens U, Reinecke H, Rostock T, Rustige J, Savelieva I, Schnabel R, Schotten U, Schwichtenberg L, Sinner MF, Steinbeck G, Stoll M, Tavazzi L, Themistoclakis S, Tse HF, Van Gelder IC, Vardas PE, Varpula T, Vincent A, Werring D, Willems S, Ziegler A, Lip GY, Camm AJ. Europace. 2016 Jan;18(1):37-50. doi: 10.1093/europace/euv304. Epub 2015 Oct 18. Review.

The European Network for Translational Research in Atrial Fibrillation (EUTRAF): objectives and initial results. Schotten U, Hatem S, Ravens U, Jaïs P, Müller FU, Goette A, Rohr S, Antoons G, Pieske B, Scherr D, Oto A, Casadei B, Verheule S, Cartlidge D, Steinmeyer K, Götsche T, Dobrev D, Kockskämper J, Lendeckel U, Fabritz L, Kirchhof P, Camm AJ; EUTRAF investigators. Europace. 2015 Oct;17(10):1457-66. doi: 10.1093/europace/euv252. Epub 2015 Sep 12. Review.

The Impact of Novel Anticoagulants: Should All AF Patients Now Be Anticoagulated? Hammwöhner M, Goette A. J Cardiovasc Pharmacol. 2015 Dec;66(6):530-9. doi: 10.1097/FJC.0000000000000297.

Dronedarone does not affect infarct volume as assessed by magnetic resonance imaging in a porcine model of myocardial infarction. Linke J, Utpatel K, Wolke C, Evert M, Kühn JP, Bukowska A, Goette A, Lendeckel U, Peters B. Mol Med Rep. 2015 Oct;12(4):5169-78. doi: 10.3892/mmr.2015.4077. Epub 2015 Jul 13.

A prospective evaluation of edoxaban compared to warfarin in subjects undergoing cardioversion of atrial fibrillation: The EdoxabaN vs. warfarin in subjectS UndeRgoing cardiovErsion of Atrial Fibrillation (ENSURE-AF) study. Lip GY, Merino J, Ezekowitz M, Ellenbogen K, Zamoryakhin D, Lanz H, Jin J, Al-Saadi N, Mercuri M, Goette A. Am Heart J. 2015 May;169(5):597-604.e5. doi: 10.1016/j.ahj.2015.02.009. Epub 2015 Feb 21.

Atrial fibrillation and rapid acute pacing regulate adipocyte/adipositas-related gene expression in the atria. Chilukoti RK, Giese A, Malenke W, Homuth G, Bukowska A, Goette A, Felix SB, Kanaan J, Wollert HG, Evert K, Verheule S, Jais P, Hatem SN, Lendeckel U, Wolke C. Int J Cardiol. 2015;187:604-13. doi: 10.1016/j.ijcard.2015.03.072. Epub 2015 Mar 23.

Depressed mood amplifies heart-related symptoms in persistent and paroxysmal atrial fibrillation patients: a longitudinal analysis--data from the German Competence Network on Atrial Fibrillation. von Eisenhart Rothe A, Hutt F, Baumert J, Breithardt G, Goette A, Kirchhof P, Ladwig KH. Europace. 2015 Sep;17(9):1354-62. doi: 10.1093/europace/euv018. Epub 2015 Mar 29.

One-year safety and quality of life outcomes in patients with atrial fibrillation on dronedarone: prospective, non-interventional study in German ambulatory care. Goette A, Benninger G, Pittrow D, Paar WD, von Stritzky B, Bosch RF. Herzschrittmacherther Elektrophysiol. 2015 Jun;26(2):148-54. doi: 10.1007/s00399-015-0360-z. Epub 2015 Mar 8.

Early subcellular Ca2+ remodelling and increased propensity for Ca2+ alternans in left atrial myocytes from hypertensive rats. Pluteanu F, Heß J, Plackic J, Nikonova Y, Preisenberger J, Bukowska A, Schotten U, Rinne A, Kienitz MC, Schäfer MK, Weihe E, Goette A, Kockskämper J. Cardiovasc Res. 2015 Apr 1;106(1):87-97. doi: 10.1093/cvr/cvv045. Epub 2015 Feb 17.

Update on management of cardiac arrhythmias in acute coronary syndromes. Willich T, Goette A. Minerva Cardioangiol. 2015 Apr;63(2):121-33. Epub 2015 Jan 22.

Redox control of cardiac remodeling in atrial fibrillation. Wolke C, Bukowska A, Goette A, Lendeckel U. Biochim Biophys Acta. 2015 Aug;1850(8):1555-65. doi: 10.1016/j.bbagen.2014.12.012. Epub 2014 Dec 13. Review.

Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial. Hindricks G, Taborsky M, Glikson M, Heinrich U, Schumacher B, Katz A, Brachmann J, Lewalter T, Goette A, Block M, Kautzner J, Sack S, Husser D, Piorkowski C, Søgaard P; IN-TIME study group. Lancet. 2014 Aug 16;384(9943):583-90.

Upstream therapy for atrial fibrillation. Goette A, Hammwöhner M, Bukowska A Herzschrittmacherther Elektrophysiol. 2014 Mar;25(1):33-40.

Bradycardic arrhythmias. Willich T, Goette A. Dtsch Med Wochenschr. 2014 Feb;139(8):381-6.

Bradycardic arrhythmias--part 1: pathophysiology and symptoms. Willich T, Goette A. Dtsch Med Wochenschr. 2014 Feb;139(7):329-33.

Depression in paroxysmal and persistent atrial fibrillation patients: a cross-sectional comparison of patients enroled in two large clinical trials. von Eisenhart Rothe AF, Goette A, Kirchhof P, Breithardt G, Limbourg T, Calvert M, Baumert J, Ladwig KH. Europace. 2014 Jun;16(6):812-9.

PPAR-? activation limits angiotensin II-mediated atrial remodeling: one drug fits all AF patients? Lendeckel U, Wolke C, Goette A. J Mol Cell Cardiol. 2014 Jan;66:165-6.

http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(14)61176-4/abstract von Prof Gerhard Hindricks, Prof Milos Taborsky, Prof Michael Glikson, Ullus Heinrich, Prof Burghard Schumacher, Prof Amos Katz, Prof Johannes Brachmann, Prof Thorsten Lewalter, Prof Andreas Goette, Prof Michael Block, Prof Josef Kautzner, Prof Stefan Sack, Prof Daniela Husser, Christopher Piorkowski, Prof Peter Søgaard, for the IN-TIME study group. The Lancet, Volume 384, Issue 9943, Pages 583 - 590, 16 August 2014.

Depression in paroxysmal and persistent atrial fibrillation patients: a cross-sectional comparison of patients enroled in two large clinical trials. von Eisenhart Rothe AF, Goette A, Kirchhof P, Breithardt G, Limbourg T, Calvert M, Baumert J, Ladwig KH.Europace. 2013 Dec 18. [Epub ahead of print]
 
PPAR-? activation limits angiotensin II-mediated atrial remodeling: One drug fits all AF patients?
Lendeckel U, Wolke C, Goette A. J Mol Cell Cardiol. 2013 Dec 7;66C:165-166. doi: 10.1016/j.yjmcc.2013.12.001. [Epub ahead of print] No abstract available.
 
Upstream therapy for atrial fibrillation in heart failure. Goette A.Heart Fail Clin. 2013 Oct;9(4):417-25, viii. doi: 10.1016/j.hfc.2013.07.010. Epub 2013 Aug 12.
 
 
Coagulation factor Xa induces an inflammatory signalling by activation of protease-activated receptors in human atrial tissue. Bukowska A, Zacharias I, Weinert S, Skopp K, Hartmann C, Huth C, Goette A. Eur J Pharmacol. 2013 Oct 15;718(1-3):114-23. doi: 10.1016/j.ejphar.2013.09.006. Epub 2013 Sep 13.
 
 
Predictors of discordance between physicians' and patients' appraisals of health-related quality of life in atrial fibrillation patients: findings from the Angiotensin II Antagonist in Paroxysmal Atrial Fibrillation Trial. von Eisenhart Rothe A, Bielitzer M, Meinertz T, Limbourg T, Ladwig KH, Goette A. Am Heart J. 2013 Sep;166(3):589-96. doi: 10.1016/j.ahj.2013.05.020. Epub 2013 Jul 10.
 
Effect of aliskiren on post-discharge outcomes among diabetic and non-diabetic patients hospitalized for heart failure: insights from the ASTRONAUT trial. Maggioni AP, Greene SJ, Fonarow GC, Böhm M, Zannad F, Solomon SD, Lewis EF, Baschiera F, Hua TA, Gimpelewicz CR, Lesogor A, Gheorghiade M; ASTRONAUT Investigators and Coordinators. Eur Heart J. 2013 Oct;34(40):3117-27. doi: 10.1093/eurheartj/eht342. Epub 2013 Sep 2.
 
Epsilon waves in giant-cell myocarditis. Vollmann D, Goette A, Kandolf R, Hasenfuss G.
Eur Heart J. 2014 Jan;35(1):9. doi: 10.1093/eurheartj/eht338. Epub 2013 Aug 29. No abstract available.
 
Potential role of telemedical service centers in managing remote monitoring data transmitted daily by cardiac implantable electronic devices: results of the early detection of cardiovascular events in device patients with heart failure (detecT-Pilot) study. Müller A, Goette A, Perings C, Nägele H, Konorza T, Spitzer W, Schulz SS, von Bary C, Hoffmann M, Albani M, Sack S, Niederlöhner A, Lewalter T. Telemed J E Health. 2013 Jun;19(6):460-6. doi: 10.1089/tmj.2012.0154. Epub 2013 Apr 9.
 
Actualización de las guías de la Sociedad Europea de Cardiología (ESC) para el manejo de la fibrilación auricular de 2010 Elaborada en colaboración con la Asociación Europea del Ritmo Cardiaco.
tores/miembros del Grupo de Trabajo, Camm AJ, Lip GY, Caterina RD, Savelieva I, Atar D, Hohnloser SH, Hindricks G, Kirchhof P; Comité de la ESC de Guías para la Práctica Clínica (CGPC), Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Anton Sirnes P, Tendera M, Torbicki A, Vahanian A, Windecker S; Revisores del documento, Vardas P, Al-Attar N, Alfieri O, Angelini A, Blömstrom-Lundqvist C, Colonna P, De Sutter J, Ernst S, Goette A, Gorenek B, Hatala R, Heidbüchel H, Heldal M, Dalby Kristensen S, Kolh P, Le Heuzey JY, Mavrakis H, Mont L, Perrone Filardi P, Ponikowski P, Prendergast B, Rutten FH, Schotten U, Van Gelder IC, Verheugt FW.
Rev Esp Cardiol. 2013 Jan;66(1):54.e1-54.e24. doi: 10.1016/j.recesp.2012.11.001. Epub 2012 Dec 25. English, Spanish. No abstract available.
 
Effect of aliskiren on postdischarge mortality and heart failure readmissions among patients hospitalized for heart failure: the ASTRONAUT randomized trial.
Gheorghiade M, Böhm M, Greene SJ, Fonarow GC, Lewis EF, Zannad F, Solomon SD, Baschiera F, Botha J, Hua TA, Gimpelewicz CR, Jaumont X, Lesogor A, Maggioni AP; ASTRONAUT Investigators and Coordinators.
JAMA. 2013 Mar 20;309(11):1125-35. doi: 10.1001/jama.2013.1954. Erratum in: JAMA. 2013 Apr 10;309(14):1461.
 
Effects of irbesartan on gene expression revealed by transcriptome analysis of left atrial tissue in a porcine model of acute rapid pacing in vivo.
Chilukoti RK, Mostertz J, Bukowska A, Aderkast C, Felix SB, Busch M, Völker U, Goette A, Wolke C, Homuth G, Lendeckel U. Int J Cardiol. 2013 Oct 3;168(3):2100-8. doi: 10.1016/j.ijcard.2013.01.007. Epub 2013 Feb 12.

Novel oral anticoagulants for stroke prevention in atrial fibrillation: Key trial findings and clinical implications. Goette A. Trends Cardiovasc Med. 2013 Jan 10. doi:pii: S1050-1738(12)00400-8. 10.1016/j.tcm.2012.10.001. [Epub ahead of print]

Enzymatic activity of DPIV and renin-angiotensin system (RAS) proteases in patients with left ventricular dysfunction and primary prevention implantable cardioverter/defibrillator (ICD). Lehmann HI, Wolke C, Malenke W, Röhl FW, Hammwöhner M, Bukowska A, Lendeckel U, Goette A. Int J Cardiol. 2012 Oct 10. doi:pii: S0167-5273(12)01189-8. 10.1016/j.ijcard.2012.09.083. [Epub ahead of print]

2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation--developed with the special contribution of the European Heart Rhythm Association. Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH, Hindricks G, Kirchhof P; ESC Committee for Practice Guidelines-CPG; Document Reviewers. Europace. 2012 Oct;14(10):1385-413. Epub 2012 Aug 24.

2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association.Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH, Hindricks G, Kirchhof P; ESC Committee for Practice Guidelines (CPG), Bax JJ, Baumgartner H, Ceconi C, Dean V, Deaton C, Fagard R, Funck-Brentano C, Hasdai D, Hoes A, Kirchhof P, Knuuti J, Kolh P, McDonagh T, Moulin C, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Torbicki A, Vahanian A, Windecker S; Document Reviewers, Vardas P, Al-Attar N, Alfieri O, Angelini A, Blömstrom-Lundqvist C, Colonna P, De Sutter J, Ernst S, Goette A, Gorenek B, Hatala R, Heidbüchel H, Heldal M, Kristensen SD, Kolh P, Le Heuzey JY, Mavrakis H, Mont L, Filardi PP, Ponikowski P, Prendergast B, Rutten FH, Schotten U, Van Gelder IC, Verheugt FW. Eur Heart J. 2012 Nov;33(21):2719-47. doi: 10.1093/eurheartj/ehs253. Epub 2012 Aug 24.  

Oxidative Stress and Microcirculatory Flow Abnormalities in the Ventricles during Atrial Fibrillation. Goette A, Bukowska A, Lillig CH, Lendeckel U.Front Physiol. 2012;3:236. doi: 10.3389/fphys.2012.00236. Epub 2012 Jul 5.

Nicotine, cigarette smoking and cardiac arrhythmia: an overview. D'Alessandro A, Boeckelmann I, Hammwhöner M, Goette A. Eur J Prev Cardiol. 2012 Jun;19(3):297-305. Review.

Therapy of atrial fibrillation in the critically ill. Willich T, Hammwöhner M, Goette A. Med Klin Intensivmed Notfmed. 2012 Jun;107(5):368-76. doi: 10.1007/s00063-012-0082-5. Epub 2012 Jun 13. German.

Atrial fibrillation and fibrosis: role of connective tissue growth factor. Lendeckel U, Wolke C, Goette A. Europace. 2012 Aug;14(8):1079-80. doi: 10.1093/europace/eus147. Epub 2012 May 22.

Atrial fibrillation: an inflammatory disease or a conformational disorder? Goette A. Can J Cardiol. 2012 Sep-Oct;28(5):529-30. doi: 10.1016/j.cjca.2012.03.016. Epub 2012 May 19.

Outpatient evaluation and management of patients with ventricular premature beats or non-sustained ventricular tachycardia. Svendsen JH, Goette A, Dobreanu D, Marinskis G, Mabo P, Blomström-Lundqvist C; Scientific Initiative Committee, European Heart Rhythm Association. Europace. 2012 Feb;14(2):294-6. doi: 10.1093/europace/eus009.

Angiotensin II-antagonist in paroxysmal atrial fibrillation (ANTIPAF) trial. Goette A, Schön N, Kirchhof P, Breithardt G, Fetsch T, Häusler KG, Klein HU, Steinbeck G, Wegscheider K, Meinertz T. Circ Arrhythm Electrophysiol. 2012 Feb;5(1):43-51. doi: 10.1161/CIRCEP.111.965178. Epub 2011 Dec 7.

Dronedarone prevents microcirculatory abnormalities in the left ventricle during atrial tachypacing in pigs. Bukowska A, Hammwöhner M, Sixdorf A, Schild L, Wiswedel I, Röhl FW, Wolke C, Lendeckel U, Aderkast C, Bochmann S, Chilukoti RK, Mostertz J, Bramlage P, Goette A. Br J Pharmacol. 2012 Jun;166(3):964-80. doi: 10.1111/j.1476-5381.2011.01784.x.

Neutral effects of statins to prevent atrial fibrillation recurrences after catheter ablation of atrial fibrillation: should we bury upstream therapy for secondary prevention of atrial fibrillation? Goette A.Heart Rhythm. 2012 Feb;9(2):179-80. doi: 10.1016/j.hrthm.2011.09.070. Epub 2011 Oct 12. No abstract available.

Induction of ventricular tachycardia during radiofrequency ablation via pulmonary vein ablation catheter in a patient with an implanted pacemaker. Hammwöhner M, Stachowitz J, Willich T, Goette A. Europace. 2012 Feb;14(2):298-9. doi: 10.1093/europace/eur260. Epub 2011 Aug 15.

Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options--a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference. Kirchhof P, Lip GY, Van Gelder IC, Bax J, Hylek E, Kaab S, Schotten U, Wegscheider K, Boriani G, Brandes A, Ezekowitz M, Diener H, Haegeli L, Heidbuchel H, Lane D, Mont L, Willems S, Dorian P, Aunes-Jansson M, Blomstrom-Lundqvist C, Borentain M, Breitenstein S, Brueckmann M, Cater N, Clemens A, Dobrev D, Dubner S, Edvardsson NG, Friberg L, Goette A, Gulizia M, Hatala R, Horwood J, Szumowski L, Kappenberger L, Kautzner J, Leute A, Lobban T, Meyer R, Millerhagen J, Morgan J, Muenzel F, Nabauer M, Baertels C, Oeff M, Paar D, Polifka J, Ravens U, Rosin L, Stegink W, Steinbeck G, Vardas P, Vincent A, Walter M, Breithardt G, Camm AJ. Europace. 2012 Jan;14(1):8-27. doi: 10.1093/europace/eur241. Epub 2011 Jul 26. Review.

Angiotensin II-Antagonist in Paroxysmal Atrial Fibrillation (ANTIPAF)-Trial. Goette A, Schön N, Kirchhof P, Breithardt G, Fetsch T, Häusler KG, Klein HU, Steinbeck G, Wegscheider K, Meinertz T. Circ Arrhythm Electrophysiol. 2011 Dec 7. [Epub ahead of print]

Neutral effects of statins to prevent atrial fibrillation recurrences after catheter ablation of atrial fibrillation: Should we bury upstream therapy for secondary prevention of atrial fibrillation? Goette A. Heart Rhythm. 2011 Oct 12. [Epub ahead of print] No abstract available.

Asymmetric dimethylarginine predicts appropriate implantable cardioverter-defibrillator intervention in patients with left ventricular dysfunction. Lehmann HI, Goette A, Martens-Lobenhoffer J, Hammwöhner M, Röhl FW, Bukowska A, Ghanem A, Klein HU, Bode-Böger SM. Europace. 2011 Oct;13(10):1428-35. Epub 2011 Jul 13.

Impact of the type of centre on management of AF patients: surprising evidence for differences in antithrombotic therapy decisions. Kirchhof P, Nabauer M, Gerth A, Limbourg T, Lewalter T, Goette A, Wegscheider K, Treszl A, Meinertz T, Oeff M, Ravens U, Breithardt G, Steinbeck G; AFNET registry investigators. Thromb Haemost. 2011 Jun 6;105(6):1010-23. Epub 2011 May 5.

The vanishing story of angiotensin II receptor blockers in the treatment of atrial fibrillation. Goette A. Europace. 2011 Apr;13(4):451-2. Epub 2011 Mar 7.

[Techniques for occlusion of the left atrial appendage: chances and risks]. Goette A. Nervenarzt. 2011 Feb;82(2):172, 174-6, 178-9.

Pathophysiological mechanisms of atrial fibrillation: a translational appraisal. Schotten U, Verheule S, Kirchhof P, Goette A. Physiol Rev. 2011 Jan;91(1):265-325. Review. Erratum in: Physiol Rev. 2011 Oct;91(4):1533.

Update on Pharmacologic Approaches To Prevent Thromboembolism in Atrial Fibrillation: Are Thrombin and Factor Xa Inhibitors the Ultimate Answer? Wolfram O, Hammwoehner M, Gramley F, Goette A. Curr Vasc Pharmacol. 2010 Dec 14.

Twenty-five years in the making: flecainide is safe and effective for the management of atrial fibrillation. Aliot E, Capucci A, Crijns HJ, Goette A, Tamargo J. Europace. 2010 Dec 7.

[Heart rhythm disturbances and their treatment according to recent recommendations]. Hammwöhner M, Goette A. Dtsch Med Wochenschr. 2010 Dec;135(49):2461-76.

Physiologic and Pathophysiologic Role of Calpain: Implications for the Occurrence of Atrial Fibrillation. Bukowska A, Lendeckel U, Bode-Böger SM, Goette A. Cardiovasc Ther. 2010 Nov 25. doi: 10.1111/j.1755-5922.2010.00245.x.

The impact of rapid atrial pacing on ADMA and endothelial NOS. Goette A, Hammwöhner M, Bukowska A, Scalera F, Martens-Lobenhoffer J, Dobrev D, Ravens U, Weinert S, Medunjanin S, Lendeckel U, Bode-Böger SM. Int J Cardiol. 2010 Oct 4.

Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). European Heart Rhythm Association; European Association for Cardio-Thoracic Surgery, Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, Van Gelder IC, Al-Attar N, Hindricks G, Prendergast B, Heidbuchel H, Alfieri O, Angelini A, Atar D, Colonna P, De Caterina R, De Sutter J, Goette A, Gorenek B, Heldal M, Hohloser SH, Kolh P, Le Heuzey JY, Ponikowski P, Rutten FH; ESC Committee for Practice Guidelines, Vahanian A, Auricchio A, Bax J, Ceconi C, Dean V, Filippatos G, Funck-Brentano C, Hobbs R, Kearney P, McDonagh T, Popescu BA, Reiner Z, Sechtem U, Sirnes PA, Tendera M, Vardas PE, Widimsky P; Document Reviewers, Vardas PE, Agladze V, Aliot E, Balabanski T, Blomstrom-Lundqvist C, Capucci A, Crijns H, Dahlöf B, Folliguet T, Glikson M, Goethals M, Gulba DC, Ho SY, Klautz RJ, Kose S, McMurray J, Perrone Filardi P, Raatikainen P, Salvador MJ, Schalij MJ, Shpektor A, Sousa J, Stepinska J, Uuetoa H, Zamorano JL, Zupan I. Europace. 2010 Oct;12(10):1360-420. No abstract available.

Guidelines for the management of atrial fibrillation: the Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). European Heart Rhythm Association; European Association for Cardio-Thoracic Surgery, Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, Van Gelder IC, Al-Attar N, Hindricks G, Prendergast B, Heidbuchel H, Alfieri O, Angelini A, Atar D, Colonna P, De Caterina R, De Sutter J, Goette A, Gorenek B, Heldal M, Hohloser SH, Kolh P, Le Heuzey JY, Ponikowski P, Rutten FH. Eur Heart J. 2010 Oct;31(19):2369-429. Epub 2010 Aug 29.

[Registry and studies of the German Competence Network on Atrial Fibrillation (AFNET)] Nabauer M, Gerth A, Kirchhof P, Goette A, Limbourg T, Sprenger C, Hoffmann B, Willems S, Doll N, Schuchert A, Oeff M, Ravens U, Meinertz T, Steinbeck G, Breithardt G. Herzschrittmacherther Elektrophysiol. 2010 Sep;21(3):153-9. German.

Guidelines for the management of atrial Fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA); Endorsed by the European Association for the Cardio-Thoracic Surgery (EACTS); Authors/Task Force Members, Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, Van Gelder IC, Al-Attar N, Hindricks G, Prendergast B, Heidbuchel H, Alfieri O, Angelini A, Atar D, Colonna P, De Caterina R, De Sutter J, Goette A, Gorenek B, Heldal M, Hohloser SH, Kolh P, Le Heuzey JY, Ponikowski P, Rutten FH. EUR Heart J 2010 Aug 29.

Registry and studies of the German Competence Network of Atrial Fibrillation (AFNET) Nabauer M, Gerth A, Kirchhof P, Goette A, Limbourg T, Sprenger C, Hoffmann B, Willems S, Doll N, Schuchert A, Oeff M, Ravens U, Meinertz T, Steinbeck G, Breithaupt G. Herzschrittmacherther Elektrophysiol. 2010 Aug 1. [Epub ahead of print] German

Rheumatoid pneumoconiosis (Caplan's syndrome). Schreiber J, Koschel D, Kekow J, Waldburg N, Goette A, Merget R. Eur J Intern Med. 2010 Jun;21(3):168-72. Epub 2010 Mar 2.PMID: 20493416 [PubMed - in process]

Aldosterone-receptor antagonism as a potential therapeutic option for atrial fibrillation. Lendeckel U, Dobrev D, Goette A. Br J Pharmacol. 2010 Apr;159(8):1581-3.PMID: 20388187 [PubMed - in process]

Clinical pharmacology and electrophysiological properties of dronedarone Lewalter T, Pittrow D, Goette A, Kirch W, Hohnloser S. Dtsch Med Wochenschr. 2010 Mar;135 Suppl 2:S43-7. Epub 2010 Mar 10

Clinical profile of the new antiarrhythmic drug dronedarone Schmitt J, Lewalter T, Pittrow D, Duray G, Goette A, Brachmann J, Hohnloser SH. Dtsch Med Wochenschr. 2010 Mar;135 Suppl 2:S38-42. Epub 2010 Mar 10.

Current antiarrhythmic drug therapy in atrial fibrillation. Goette A. Dtsch Med Wochenschr. 2010 Mar;135 Suppl 2:S33-7. Epub 2010 Mar 10.

Recent advances in the pharmacological treatment of cardiac arrythmias Gramley F, Himmrich E, Mollnau H, Theis C, Hammwohner M, Goette A. Drugs Today (Barc). 2009 Nov;45(11):807-24.

Changes in microRNA-1 expression and IK1 up-regulation in human atrial fibrillation. Girmatsion Z, Biliczki P, Bonauer A, Wimmer-Greinecker G, Scherer M, Moritz A, Bukowska A, Goette A, Nattel S, Hohnloser SH, Ehrlich JR. Heart Rhythm. 2009 Dec;6(12):1802-9. Epub 2009 Sep 3.

Stroke prevention versus bleeding risk of vitamin-K antagonists: a double-edged sword in patients with atrial fibrillation who require surgery. Dobrev D, Goette A, Ravens U. Cardiovasc Ther. 2009 Winter;27(4):223-5

Sudden cardiac death stratification in asymptomatic ventricular preexcitation. Cantú F, Goette A; EHRA Scientific Initiatives Committee. Europace. 2009 Nov;11(11):1536-7.

Calpain in Atrial Fibrillation: Friend or Foe? : Editorial to: "Anti-apoptotic effects of a calpain inhibitor on cardiomyocytes in a canine rapid atrial fibrillation model" by Yue Li et al. Lendeckel U, Goette A. Cardiovasc Drugs Ther. 2009 Oct 8. [Epub ahead of print] No abstract available.

Prospective, multicentre validation of a simple, patient-operated electrocardiographic system for the detection of arrhythmias and electrocardiographic changes. Kaleschke G, Hoffmann B, Drewitz I, Steinbeck G, Naebauer M, Goette A, Breithardt G, Kirchhof P. Europace. 2009 Oct;11(10):1362-8.

Cardiac-resynchronization therapy for the prevention of heart-failure events. Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP, Estes NA 3rd, Foster E, Greenberg H, Higgins SL, Pfeffer MA, Solomon SD, Wilber D, Zareba W. MADIT-CRT Trial Investigators.N Engl J Med. 2009 Oct 1;361(14):1329-38. Epub 2009 Sep 1.

Gender and age-dependent differences in the bradykinin-degradation within the pericardial fluid of patients with coronary artery disease. Bechtloff R, Goette A, Bukowska A, Kähne T, Peters B, Huth C, Wolke C, Lendeckel U. Int J Cardiol. 2009 Jul 8. [Epub ahead of print]

Early and comprehensive management of atrial fibrillation: executive summary of the proceedings from the 2nd AFNET-EHRA consensus conference 'research perspectives in AF'. Kirchhof P, Bax J, Blomstrom-Lundquist C, Calkins H, Camm AJ, Cappato R, Cosio F, Crijns H, Diener HC, Goette A, Israel CW, Kuck KH, Lip GY, Nattel S, Page RL, Ravens U, Schotten U, Steinbeck G, Vardas P, Waldo A, Wegscheider K, Willems S, Breithardt G. Eur Heart J. 2009 Dec;30(24):2969-77c. Epub .

Early and comprehensive management of atrial fibrillation: proceedings from the 2nd AFNET/EHRA consensus conference on atrial fibrillation entitled 'research perspectives in atrial fibrillation'. Kirchhof P, Bax J, Blomstrom-Lundquist C, Calkins H, Camm AJ, Cappato R, Cosio F, Crijns H, Diener HC, Goette A, Israel CW, Kuck KH, Lip GY, Nattel S, Page RL, Ravens U, Schotten U, Steinbeck G, Vardas P, Waldo A, Wegscheider K, Willems S, Breithardt G. Europace. 2009 Jul;11(7):860-85. Epub 2009 Jun 16. No abstract available.

Nicotine, atrial fibrosis, and atrial fibrillation: do microRNAs help to clear the smoke? Goette A. Cardiovasc Res. 2009 Aug 1;83(3):421-2. Epub 2009 Jun 5. No abstract available.

The effects of G-CSF-induced mobilization of progenitor cells are limited by ADMA. Goette A, Wolfram O, Jentsch-Ullrich K, Martens-Lobenhoffer J, Scalera F, Lendeckel U, Bode-Böger SM. Int J Cardiol. 2009 Mar 19. [Epub ahead of print]

Acute atrial tachyarrhythmia induces angiotensin II type 1 receptor-mediated oxidative stress and microvascular flow abnormalities in the ventricles. Goette A, Bukowska A, Dobrev D, Pfeiffenberger J, Morawietz H, Strugala D, Wiswedel I, Röhl FW, Wolke C, Bergmann S, Bramlage P, Ravens U, Lendeckel U. Eur Heart J. 2009 Jun;30(11):1411-20. Epub 2009 Mar 5.

Severe mitral regurgitation in a patient with a bluish right sclera: an 'extension' of Caplan's syndrome to the heart and eye. Goette A, Huth C, Behrens-Baumann W, Evert M. Eur J Intern Med. 2009 Jan;20(1):e1-2. Epub 2008 Mar 4. No abstract available.

Atrial expression of endothelial nitric oxide synthase in patients with and without atrial fibrillation. Bukowska A, Röcken C, Erxleben M, Röhl FW, Hammwöhner M, Huth C, Ebert MP, Lendeckel U, Goette A. Cardiovasc Pathol. 2009 Feb 10. [Epub ahead of print]

The Registry of the German Competence NETwork on Atrial Fibrillation: patient characteristics and initial management. Nabauer M, Gerth A, Limbourg T, Schneider S, Oeff M, Kirchhof P, Goette A, Lewalter T, Ravens U, Meinertz T, Breithardt G, Steinbeck G. Europace. 2009 Apr;11(4):423-34. Epub 2009 Jan 18

The German Competence Network on Atrial Fibrillation (AFNET). Breithardt G, Dobrev D, Doll N, Goette A, Hoffmann B, Kirchhof P, Köster I, Kuck KH, Leute A, Meinertz T, Näbauer M, Oeff M, Ravens U, Schuchert A, Sprenger C, Steinbeck G, Willems S. Herz. 2008 Dec;33(8):548-55.

Performance and survival of transvenous defibrillation leads: need for a European data registry. Goette A, Cantu F, van Erven L, Geelen P, Halimi F, Merino JL, Morgan JM; Scientific Initiative Committee of the European Heart Rhythm Association. Europace. 2009 Jan;11(1):31-4. Epub 2008 Nov 11.